Forest Laboratories, LLC Sustainability Profile
Forest Laboratories, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 1954, the company has established itself as a leader in developing innovative treatments across various therapeutic areas, including psychiatry, neurology, and respiratory health. With a strong focus on research and development, Forest Laboratories is renowned for its unique portfolio of prescription medications, which address critical health issues. The company has achieved significant milestones, including the successful launch of several blockbuster drugs that have transformed patient care. Recognised for its commitment to quality and efficacy, Forest Laboratories continues to maintain a strong market position, contributing to advancements in healthcare and improving the lives of patients worldwide.
DitchCarbon Score
How does Forest Laboratories, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Forest Laboratories, LLC's score of 37 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Forest Laboratories, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of AbbVie Inc., which influences its climate commitments and initiatives. While there are no documented reduction targets or specific climate pledges from Forest Laboratories, it is important to note that any potential targets or initiatives may be cascaded from AbbVie Inc. at a corporate level. AbbVie Inc. has established science-based targets (SBTi) and other climate-related initiatives that may impact Forest Laboratories' sustainability strategies. As a subsidiary, Forest Laboratories may align its practices with the broader environmental goals set by AbbVie Inc., which includes commitments to reduce emissions across various scopes. However, without specific data or targets from Forest Laboratories itself, the details of its climate commitments remain vague. In summary, while Forest Laboratories, LLC does not currently provide emissions data or specific reduction targets, it is positioned within a corporate structure that may influence its climate actions through AbbVie Inc.'s established initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2005 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 28,218,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 59,189,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Forest Laboratories, LLC's Industry?
How Carbon Intensive is Forest Laboratories, LLC's Location?
Forest Laboratories, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Forest Laboratories, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
